Discovery of Tetrahydropyrazolopyrimidine Carboxamide Derivatives As Potent and Orally Active Antitubercular Agents
Year: 2013
Type: article
Abstract: Tetrahydropyrazolo[1,5-a]pyrimidine scaffold was identified as a hit series from a Mycobacterium tuberculosis (Mtb) whole cell high through-put screening (HTS) campaign. A series of derivatives of this class were synthesized to evaluate their structure-activity relationship (SAR) and structure-property relationship (SPR). Compound 9 had a promising in vivo DMPK profile in mouse and exhibited potent in vivo activity in a mouse efficacy model, achieving a reduction of 3.5 log CFU of Mtb after oral administration to infected mice once a day at 100 mg/kg for 28 days. Thus, compound 9 is a potential candidate for inclusion in combination therapies for both drug-sensitive and drug-resistant TB.
Source: ACS Medicinal Chemistry Letters
DOI: 10.1021/ml400071a
Authors: Fumiaki Yokokawa, Gang Wang, Wai Ling Chan, Shi Hua Ang, Josephine Wong, Ida Ma, Srinivasa P S Rao, Ujjini Manjunatha, Suresh B Lakshminarayana, Maxime Herve, Cyrille Kounde, Bee Huat Tan, Pamela Thayalan, Seow Hwee Ng, Mahesh Nanjundappa, Sindhu Ravindran, Peck Gee, Maria Tan, Liu Wei, Anne Goh, Pei-Yu Chen, Kok Sin Lee, Chen Zhong, Trixie Wagner, Ina Dix, Arnab K. Chatterjee, Kevin Pethe, Kelli Kuhen, Richard Glynne, Paul Smith, Pablo Bifani, Jan Jiricek
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W2052284685
